Flunixon Injection
Flunixon Injection contains 50mg/mL flunixin (as meglumine) in a sterile glass vial. A non-steroidal, anti-inflammatory, analgesic and antipyretic, with anti-prostaglandin effects
Target Species: Beef cattle, dairy cattle, horses, pigs and dogs
-
Active Ingredient
50mg/mL flunixin (as meglumine)
-
Pharmaceutical Form
Solution for injection
-
Indications
This product is a non-steroidal, anti-inflammatory, analgesic and antipyretic, with anti-prostaglandin effects. It provides effective anti-inflammatory and analgesic action in a wide range of musculoskeletal disorders in horses, dogs, cattle and pigs. Administration has resulted in effective visceral analgesia in cases of equine colic due to flatulence or inflammatory causes. It has been used successfully to reduce the adverse haemodynamic changes which characterise endotoxic shock in both horses and dogs. The agent is also recommended as an adjunct to the therapy of MMA syndrome in sows.
-
Dosage
Horses: 1.1mg/kg (1mL/45kg) bodyweight daily for up to 5 days, by intravenous or intramuscular injection.
Cattle: 1.1-2.2mg/kg (1-2mL/45kg) bodyweight daily for 3 to 5 days, by intravenous or intramuscular injection. Pigs: 1.1-2.2mg/kg (1-2mL/45kg) bodyweight daily for up to 3 days, by deep intramuscular injection. Dogs: 1mg/kg (0.2mL/10kg) bodyweight daily for up to 3 days, by intravenous or intramuscular injection.
Prefer to speak directly to a member of our team?
Norbrook Laboratories Australia Pty Ltd.
We are open Mon - Fri 9:00am - 5:00pm
Please note: Product information presented on this website is intended only as a brief summary of Norbrook products for your convenience. Not all products or indications are licensed in every country and may be subject to further local variations. For specific product information you should always consult a healthcare professional from your region or visit the local government agency website for the most up to date information. Please see our terms and conditions for further information.